When it comes to treating pleural mesothelioma, thoracic surgeon Dr. Joseph Friedberg sees a ray of light for patients suffering from the disease.
Pleural and Lung Cancer
Works for Specialty Center
Board Certified in Surgery
Board Certified in Thoracic and Cardiac Surgery
Friedberg, Division Head of Thoracic Surgery at the University of Maryland School of Medicine, found that patients who underwent lung-sparing surgery in combination with photodynamic therapy showed superior overall survival rates than comparable patients who opted for the more traditional treatment of having an entire lung removed.
Dr. Friedberg was on the team of researchers that worked to develop a lung cancer vaccine.
He previously was the chief of thoracic surgery and co-director of the Penn Mesothelioma and Pleural Diseases Program at the University of Pennsylvania Medical Center.
In hopes of developing treatments for advanced cancers and malignant mesothelioma, Friedberg has spearheaded several investigational trials. Included in those studies is research on the potential of a lung cancer vaccine.
Friedberg began seeing patients at the Greenebaum Cancer Center in late 2014, joining a multidisciplinary team of specialists . Together they review each case to develop a treatment plan specific to each patient.
Our primary motivation in attempting the lung-sparing surgery was preservation of quality of life. We were completely caught off guard when the analysis revealed a significantly longer survival for the patients who retained both lungs.
– Dr. Friedberg
We can help you or a loved one get in contact with Dr. Friedberg and find the treatment that's best for you.Get Started Today
Friedberg received his medical degree from Harvard Medical School and completed specialized training in thoracic surgery at Brigham and Women’s Hospital. He is board-certified in thoracic surgery and is considered an expert at video-thoracoscopic procedures for treatment of chest diseases. His research findings have been profiled in several professional journals, including Clinical Cancer Research and the Journal of Clinical Oncology.
Disclaimer: Dr. Joseph S. Friedberg has no professional affiliation with Asbestos.com.
Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers. Read More